Ha seleccionado la visión en Inglés
Descriptor en español: |
Carboxipeptidasa B2
| ||||||
Descriptor en inglés: | Carboxypeptidase B2 | ||||||
Descriptor en portugués: | Carboxipeptidase B2 | ||||||
Descriptor en francés: | Carboxypeptidase B2 | ||||||
Término(s) alternativo(s): |
Arginine Carboxypeptidase Carboxypeptidase B2, Plasma Carboxypeptidase R Carboxypeptidase U Plasma Carboxypeptidase B2 Plasma Procarboxypeptidase B Procarboxypeptidase U Thrombin Activatable Fibrinolysis Inhibitor Thrombin-Activatable Fibrinolysis Inhibitor Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) |
||||||
Código(s) jeráquico(s): |
D08.811.277.656.350.245.125 D08.811.277.656.350.555.225 D08.811.277.656.675.555.225 D08.811.277.656.837.092 |
||||||
Identificador Único RDF: | https://id.nlm.nih.gov/mesh/D025901 | ||||||
Nota de alcance: | A carboxypeptidase that removes C-terminal lysine or arginine from peptides and proteins. Carboxypeptidase B2 (CPB2) is released into the circulation as a proenzyme which is activated by the THROMBIN-THROMBOMODULIN complex. Activated CPB2 is involved in modulating a variety of processes by cleaving and inactivating various circulating proteins and peptides that are its substrates including FIBRIN; KININS; and ANAPHYLATOXINS. |
||||||
Calificadores permitidos: |
AD administration & dosage AE adverse effects AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Número de registro: | EC 3.4.17.20 | ||||||
Indexación anterior: |
Carboxypeptidases (1979-2001) Lysine Carboxypeptidase (1994-2001) |
||||||
Nota Pública de MeSH: | 2015; see CARBOXYPEPTIDASE U 2002-2014; CARBOXYPEPTIDASE U (NM) was indexed under CARBOXYPEPTIDASES 1994-2001; for ARGININE CARBOXYPEPTIDASE see LYSINE CARBOXYPEPTIDASE 1997-2001 |
||||||
Nota de historia: | 2015 (2002); use CARBOXYPEPTIDASE U (NM) 1994-2001 and LYSINE CARBOXYPEPTIDASE 1997-2001 |
||||||
Identificador de DeCS: | 36082 | ||||||
ID del Descriptor: | D025901 | ||||||
Documentos indizados en la Biblioteca Virtual de Salud (BVS): | Haga clic aquí para acceder a los documentos de la BVS | ||||||
Fecha de establecimiento: | 01/01/2002 | ||||||
Fecha de entrada: | 25/07/2001 | ||||||
Fecha de revisión: | 06/06/2014 |
-
-
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes
|
Carboxypeptidase B2
- Concepto preferido
Procarboxypeptidase U
- Relacionado pero no más amplio ni más estrecho
UI del concepto |
M0376430 |
Nota de alcance | A carboxypeptidase that removes C-terminal lysine or arginine from peptides and proteins. Carboxypeptidase B2 (CPB2) is released into the circulation as a proenzyme which is activated by the THROMBIN-THROMBOMODULIN complex. Activated CPB2 is involved in modulating a variety of processes by cleaving and inactivating various circulating proteins and peptides that are its substrates including FIBRIN; KININS; and ANAPHYLATOXINS. |
Término preferido | Carboxypeptidase B2 |
Término(s) alternativo(s) |
Arginine Carboxypeptidase Carboxypeptidase B2, Plasma Carboxypeptidase R Carboxypeptidase U Plasma Carboxypeptidase B2 Thrombin Activatable Fibrinolysis Inhibitor Thrombin-Activatable Fibrinolysis Inhibitor Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) |
UI del concepto |
M0368256 |
Término preferido | Procarboxypeptidase U |
Término(s) alternativo(s) |
Plasma Procarboxypeptidase B |
Queremos sus comentarios sobre el nuevo sitio web de DeCS / MeSH
Lo invitamos a completar una encuesta que no tomará más de 3 minutos.
Ir a la encuesta